Riluzole Oral Suspension shortage
Current 4 presentations · 1 manufacturers · first FDA posting Jan 26, 2024 · last update Oct 15, 2026
Manufacturers: EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)
Stated reasons (per FDA): Requirements related to complying with good manufacturing practices
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: TBD | Posted Jan 26, 2024 Updated Oct 15, 2026 |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current Available |
— | Posted Jan 26, 2024 Updated Oct 15, 2026 | |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current Available |
— | Posted Jan 26, 2024 Updated Oct 15, 2026 | |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current Available |
— | Posted Jan 26, 2024 Updated Oct 15, 2026 |